Mansukh Mandaviya, Union Minister for Health and Family Welfare addressed the closing session of 4th Indo-US Health Dialogue hosted by India.
The two-day Dialogue leveraged as a platform to deliberate upon multiple ongoing collaborations in the health sector between the two countries. The issues germane to strengthening of epidemiological research and surveillance, vaccine development, One Health, zoonotic and vector-borne diseases, health systems and health policies etc. were discussed during the two day dialogue.
Two MoUs were also signed at the concluding session. One MoU was signed between the Ministry of Health & Family Welfare of the Republic of India and Department of Health and Human Services of the USA apropos of cooperation in the field of Health and Biomedical sciences. Another MoU was signed between Indian Council of Medical Research (ICMR) & National Institute of Allergy and Infectious Diseases (NIAID) for cooperation on International Centre for Excellence in Research (ICER).
Mandavia said that Indian generic drugs have helped in bringing down the cost of treatment of various diseases globally. “India supplies nearly all the developing world’s high-quality generic medicines. We are also the largest manufacturer of anti-TB drugs. Leveraging on this capability, we can supply affordable high-quality medication for patients the world over," he said.